<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969159</url>
  </required_header>
  <id_info>
    <org_study_id>insulin - sepsis</org_study_id>
    <nct_id>NCT04969159</nct_id>
  </id_info>
  <brief_title>The Degree, Duration and Frequency of Insulin Resistance in Non-operated Patients With Sepsis</brief_title>
  <official_title>Insulin Resistance in Septic Patients in the Acute Phase and After Discharge From Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jens Rikardt Andersen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgery induces insulin resistance lasting for 2-3 weeks. We wanted to elucidate if&#xD;
      stress-metabolic, medical conditions carry the same effect.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Insulin resistance is well documented after surgery in a severity positively&#xD;
      correlated to the degree of trauma (Thorell et al. 1999; Chambrier et al. 2000). Similar&#xD;
      phenomena have been described in severely ill patients in ICU with consequences for the&#xD;
      survival (Van den Berghe et al. 2001; The NICE-SUGAR Study Investigators 2009). The&#xD;
      documentation, however, is scarce and the extent is unknown in acutely ill patients with&#xD;
      sepsis.&#xD;
&#xD;
      Method: Adult, consecutive, non-diabetic patients with elevated CRP, leukocyte counts,&#xD;
      SOFA-score of ≥ 2 were monitored with fasting p-C-peptide, blood glucose, CRP, leukocyte&#xD;
      count and HOMA-IR at admittance, discharge and at two follow-up visits 2 weeks and 4 weeks&#xD;
      after admission. Blood glucose levels were measured continuously during the whole study&#xD;
      period with a flash glucose monitor mounted on the patients' upper arm. The diagnosis was&#xD;
      sepsis, urosepsis, pneumonia, erysipecosis, bacteremia, infection with unknow focus and&#xD;
      covid-19.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>continous blood glucose</measure>
    <time_frame>4 weeks</time_frame>
    <description>flash glucose monitor on the upper arm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>C-peptide</measure>
    <time_frame>4 weeks</time_frame>
    <description>plasma concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA-IR</measure>
    <time_frame>4 weeks</time_frame>
    <description>calculated glucose load test</description>
  </secondary_outcome>
  <enrollment type="Actual">18</enrollment>
  <condition>Sepsis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>standard treatment in the clinical routine</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive adults acutely admnitted to hospital with diagnosed sepsis on bacterial basis&#xD;
        or on basis of covid-19&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  elevated CRP on acute asdmission&#xD;
&#xD;
          -  elevated leukocyte count on admission&#xD;
&#xD;
          -  SOFA-score ≥ 2&#xD;
&#xD;
          -  diagnosis: bacterial sepsis&#xD;
&#xD;
          -  full age and authority&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  not able to understand the protocol&#xD;
&#xD;
          -  not able to co-operate&#xD;
&#xD;
          -  diabetes mellitus of any kind&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens R Andersen, MD,MPA</last_name>
    <role>Study Director</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of endocrinology, Slagelse Hospiatl</name>
      <address>
        <city>Slagelse</city>
        <zip>4200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 9, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>July 9, 2021</last_update_submitted>
  <last_update_submitted_qc>July 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Jens Rikardt Andersen</investigator_full_name>
    <investigator_title>Associate Professor, Primary Investigator</investigator_title>
  </responsible_party>
  <keyword>septicaemia</keyword>
  <keyword>insulin resitance</keyword>
  <keyword>continous blood glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no plans</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

